[PDF] Idéation et conduites suicidaires des migrants en situation de

View - Download Idéation et conduites suicidaires des migrants en situation de

Previous PDF

Next PDF

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
o o o o o o o 39
o o o

LQ ILQH

40
41
42
43
44
45
46
47

LLB =RQH JpRJUMSOLTXH

48
49
50
51
52
53
54
55
56
57

1RQŃRQIRUPLPp GX ŃORL[ GX PpGLŃMPHQP MX[ GLIIpUHQPV ŃRQVHQVXV

o o o o

FRQPUHLQGLŃMPLRQMNVROXH

HQGLŃMPLRQ QRQ PUMLPpH

5HGRQGMQŃH

0pGLŃMPHQP QRQ LQGLTXp

58

HQPHUMŃPLRQ PpGLŃMPHQPHXVHPMÓHXUH

59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
a 92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159

1. Legrain S, others. Consommation médicamenteuse chez le sujet âgé. Consomm Prescr

Iatrogénie Obs [Internet]. 2005 [cité le 15 sept 2016]; Disponible sur: http://www.has-

4_51_580.pdf

2. Bilan démographique 2014 | Insee [Internet]. [cité le 23 juin 2017]. Disponible sur:

3. Stamford BA. Physiological effects of training upon institutionalized geriatric men. J

Gerontol. 1972;27(4):451̻5.

4. Lang PO. Le processus de fragilité : que comprendre de la physiopathologie ? NPG

Neurol - Psychiatr - Gériatrie. 2013;13(73):28̻ 34.

5. Haute Autorité de Santé. Comment prendre en charge les personnes âgées fragiles en

ambulatoire ? [Internet]. [cité le 30 juin 2017]. Disponible sur: https://www.has-

6. Rockwood K, Fox RA, Stolee P, Robertson D, Beattie BL. Frailty in elderly people: an

evolving concept. CMAJ Can Med Assoc J J Assoc Medicale Can. 1994;150(4):489̻95.

7. Vellas B, Gillette-Guyonnet S, Nourhashémi F, Rolland Y, Lauque S, Ousset PJ, et al.

[Falls, frailty and osteoporosis in the elderly: a public health problem]. Rev Med

Interne. 2000;21(7):608̻13.

8. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in

older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci.

2001;56(3):M146-156.

9. Rolland Y, Benetos A, Gentric A, Ankri J, Blanchard F, Bonnefoy M, et al. [Frailty in

older population: a brief position paper from the French society of geriatrics and gerontology]. Geriatr Psychol Neuropsychiatr Vieil. 2011;9(4):387̻ 90.

10. Subra J, Gillette-Guyonnet S, Cesari M, Oustric S, Vellas B, Plateforme É de la. Intégrer

la plateforme d'Ġǀaluation des fragilitĠs et de prĠǀention de la dépendance. Cah

Année Gérontologique. 2012;4(3):269̻78.

160

11. Rolland Y, Abellan van Kan G, Bénétos A, Blain H, Bonnefoy M, Chassagne P, et al.

Frailty, osteoporosis and hip fracture: causes, consequences and therapeutic perspectives. J Nutr Health Aging. 2008;12(5):335̻46. 12 . Internal Classification of Impairments, Disabilities, and Handicaps. A manual of classification relating to the consequences of disease [Internet]. [cité le 30 juin 2017].

Disponible sur:

13. Rolland Y, Andrieu S, Crochard A, Goni S, Hein C, Vellas B. Psychotropic drug

consumption at admission and discharge of nursing home residents. J Am Med Dir

Assoc. 2012;13(4):407.e7-12.

14. OECD. Recipients of long-term care. In: Health at a Glance 2013: OEDC Indicators.

OECD Publishing. p178-179. [Internet]. Paris: Organisation for Economic Co-operation and Development; 2013 [cité le 16 juin 2017]. Disponible sur: http://www.oecd-

15. Ness J, Ahmed A, Aronow WS. Demographics and payment characteristics of nursing

home residents in the United States: a 23-year trend. J Gerontol A Biol Sci Med Sci.

2004;59(11):1213̻

7.

16. Harris-Kojetin L, Sengupta M, Park-Lee E, Valverde R. Long-Term Care Services in the

United States: 2013 Overview. Vital Health Stat 3. 2013;(37):1̻ 107.
oct 2014 [cité le 16 juin 2017]; Disponible sur:

18. Morin L. Les établissements d'hébergement pour personnes âgées dépendantes en

France métropolitaine en 2014 [Internet]. [cité le 30 juin 2017]. Disponible sur: 19

. Dossier Solidarité et Santé. Les personnes âgées en institution [Internet]. [cité le 23

juin 2017]. Disponible sur: http://drees.solidarites- sante.gouv.fr/IMG/pdf/dossier201122.pdf

20. Dossier Solidarité et Santé. Accessibilité de l'offre en établissements d'hébergement

pour personnes âgées : enjeux territoriaux [Internet]. [cité le 30 juin 2017]. Disponible sur: http://drees.solidarites-sante.gouv.fr/IMG/pdf/article36.pdf

21. Ankri J. Le risque iatrogène médicamenteux chez le sujet âgé, IATROGENIC DRUG RISK

IN ELDERLY PATIENTS. Gérontologie Société. 2009;25 / n° 103(4):93̻ 106.
161
[cité le 30 juin 2017]. Disponible sur:

23. Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, et al. Incidence and

preventability of adverse drug events among older persons in the ambulatory setting.

JAMA. 2003;289(9):1107̻16.

24. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug

reactions as cause of admission to hospital: prospective analysis of 18 820 patients.

BMJ. 2004;329(7456):15̻

9.

25. Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse

drug reactions: a systematic review of prospective observational studies. Ann

Pharmacother. 2008;42(7):1017̻25.

26. Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, et al. Incidence and

preventability of adverse drug events among older persons in the ambulatory setting.

JAMA. 2003;289(9):1107̻

16.

27. Turnheim K. Drug therapy in the elderly. Exp Gerontol. 2004;39(11̻

12):1731̻8.

28. Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and

pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol.

2004;57(1):6̻14.

29. Merle L, Laroche M, Charmes J. In: Pharmacologie et pharmacovigilance du sujet âgé

Veyssier. Elsevier. 2005. p. 37̻54.

30. Bowie MW, Slattum PW. Pharmacodynamics in older adults: a review. Am J Geriatr

Pharmacother. 2007;5(3):263̻

303.

31. Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly

people. Lancet. 2007;370(9582):185̻ 91.

32. Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation

of multiple medications in older adults: addressing polypharmacy. Arch Intern Med.

2010;170(18):1648̻

54.

33. Handler SM, Wright RM, Ruby CM, Hanlon JT. Epidemiology of medication-related

adverse events in nursing homes. Am J Geriatr Pharmacother. 2006;4(3):264̻ 72.

34. Rolland Y, Hermabessière S, Kan GA van, Gérard S, Guyonnet-Gillette S, Vellas B.

Gérontologique. 2009;1(1):35̻

41.
162

35. Moore KL, Boscardin WJ, Steinman MA, Schwartz JB. Patterns of chronic co-morbid

medical conditions in older residents of U.S. nursing homes: differences between the sexes and across the agespan. J Nutr Health Aging. 2014;18(4):429̻ 36.

36. Roth MT, Ivey JL. Self-reported medication use in community-residing older adults: A

pilot study. Am J Geriatr Pharmacother. 2005;3(3):196̻ 204.

37. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers

criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716̻24.

38. Jokanovic N, Tan ECK, Dooley MJ, Kirkpatrick CM, Bell JS. Prevalence and factors

associated with polypharmacy in long-term care facilities: a systematic review. J Am

Med Dir Assoc. 2015;16(6):535.e1-12.

39. Payne RA, Avery AJ. Polypharmacy: one of the greatest prescribing challenges in

general practice. Br J Gen Pract J R Coll Gen Pract. 2011;61(583):83̻4.

40. Gurwitz JH, Field TS, Judge J, Rochon P, Harrold LR, Cadoret C, et al. The incidence of

adverse drug events in two large academic long-term care facilities. Am J Med.

2005;118(3):251̻8.

41. Nguyen JK, Fouts MM, Kotabe SE, Lo E. Polypharmacy as a risk factor for adverse drug

reactions in geriatric nursing home residents. Am J Geriatr Pharmacother.

2006;4(1):36̻41.

42. Tjia J, Gurwitz JH, Briesacher BA. Challenge of changing nursing home prescribing

culture. Am J Geriatr Pharmacother. 2012;10(1):37̻ 46.

43. Bronskill SE, Gill SS, Paterson JM, Bell CM, Anderson GM, Rochon PA. Exploring

variation in rates of polypharmacy across long term care homes. J Am Med Dir Assoc.

2012;13(3):309.e15-21.

a European perspective. Drugs Aging. 2012;29(6):423̻ 5. systematic review. J Gerontol A Biol Sci Med Sci. 2007;62(10):1172̻ 81.
quotesdbs_dbs43.pdfusesText_43

[PDF] erreur faute philosophie

[PDF] oulala définition

[PDF] code promo oulala deals

[PDF] oulala chanson

[PDF] oulala oiseau

[PDF] classement des cyclones les plus puissants

[PDF] classement tempete cyclone ouragan

[PDF] cours hackers pdf

[PDF] difference entre tempete et cyclone

[PDF] irma 1 jour 1 actu

[PDF] un jour une actu irma

[PDF] un jour une actu typhon

[PDF] 1 jour 1 actu ouragan

[PDF] ouragan irma le plus puissant

[PDF] 1 jour 1 question ouragan